A detailed history of Alliancebernstein L.P. transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 34,990 shares of INZY stock, worth $102,520. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,990
Previous 32,650 7.17%
Holding current value
$102,520
Previous $145,000 25.52%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.31 - $6.0 $10,085 - $14,040
2,340 Added 7.17%
34,990 $182,000
Q2 2024

Aug 14, 2024

BUY
$4.33 - $7.31 $62,222 - $105,044
14,370 Added 78.61%
32,650 $145,000
Q3 2023

Nov 14, 2023

BUY
$4.09 - $7.0 $74,765 - $127,960
18,280 New
18,280 $76,000

Others Institutions Holding INZY

About Inozyme Pharma, Inc.


  • Ticker INZY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,145,700
  • Market Cap $118M
  • Description
  • Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...
More about INZY
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.